Explore our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts.

Notes: This data is based on lobbying disclosure filings and, as such, provides a lagging and at times incomplete account of lobbying activity. What’s more, it captures only lobbying that takes place at the federal level, meaning state-level efforts are not reflected here. Please also note that filings must only specify the approximate amount spent where it exceeds $5,000. Otherwise, a $0 figure may be reported.

Federal Lobbying by Psychedelic Drug Developers

Federal Lobbying by Psychedelic Non-Profits

Overview of Federal Psychedelic Lobbying Spend

Pα+ delivers the policy intelligence serious stakeholders rely on. Get in-depth coverage of psychedelic policy and regulation—tracking developments from Capitol Hill to state legislatures. With expert analysis and curated insights, Pα+ keeps you informed on the decisions shaping the future of psychedelics. Subscribe today.

Join Today

Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.

Monthly $20 Annually $200

Subscribe to our
free newsletter


By signing up, you agree to our privacy policy. You can unsubscribe at any time.

Learn More About

Group, team &
corporate plans


Aside from group pricing, we also offer bespoke reports and regular briefings. Get in touch to discuss.